(Q54708979)

3 June 2018

title

Paraoxonase 1 Gln/Arg polymorphism is associated with the risk of microangiopathy in Type 2 diabetes mellitus. (English)

1 reference

3 June 2018

0 references

Murata M

1

1 reference

3 June 2018

Maruyama T

2

1 reference

3 June 2018

Suzuki Y

3

1 reference

3 June 2018

Saruta T

4

1 reference

3 June 2018

Ikeda Y

5

1 reference

3 June 2018

publication date

1 August 2004

1 reference

3 June 2018

published in

Diabetic Medicine

1 reference

3 June 2018

volume

21

1 reference

3 June 2018

issue

8

1 reference

3 June 2018

page(s)

837-844

1 reference

3 June 2018

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01252.X

Familial factors determine the development of diabetic nephropathy in patients with IDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01252.X

Blood-viscosity in diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01252.X

Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01252.X

Human and rabbit paraoxonases: purification, cloning, sequencing, mapping and role of polymorphism in organophosphate detoxification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01252.X

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01252.X

A general method for isolation of high molecular weight DNA from eukaryotes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01252.X

Polymorphisms of human paraoxonase 1 gene (PON1) and susceptibility to diabetic nephropathy in type I diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01252.X

Paraoxonase gene cluster is a genetic marker for early microvascular complications in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01252.X

Genotyping of the human platelet antigen systems 1 through 5 by multiplex polymerase chain reaction and ligation-based typing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01252.X

Studies on human serum paraoxonase/arylesterase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01252.X

Paraoxonase genotypes, lipoprotein lipase activity, and HDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01252.X

Genetic polymorphism of paraoxonase and the risk of coronary heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01252.X

Relationships between polymorphisms of the human serum paraoxonase gene and insulin sensitivity in Japanese patients with Type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01252.X

10.1111/J.1464-5491.2004.01252.X

21 January 2018

Identifiers

DOI

1 reference

3 June 2018

1 reference

3 June 2018